NCT01017172View on ClinicalTrials.gov

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
HIV-1 InfectionCancerImmunosuppression
Interventions
OTHER

serologic testing

Serologic testing will be performed baseline, day 21 and day 42

Trial Locations (1)

60590

RECRUITING

Hivcenter, Frankfurt

Sponsors

Lead Sponsor

Goethe University
All Listed Sponsors
collaborator

HIVCENTER

UNKNOWN

lead

Goethe University

OTHER